4
Changes in Ownership
Ginkgo Bioworks Holdings, Inc. Filed Acc 0001127602-23-023812
See remarks sold 41,417 shares at $2.24 ($92,567)
- See remarks acquired 85,043 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dmytruk Mark E. See remarks | 2023-09-01 | Option exercise | +65,282 | 565,241 | D | ||
| Dmytruk Mark E. See remarks | 2023-09-01 | Option exercise | +18,125 | 583,366 | D | ||
| Dmytruk Mark E. See remarks | 2023-09-01 | Option exercise | +1,636 | 585,002 | D | ||
| Dmytruk Mark E. See remarks | 2023-09-05 | Sale | −41,417 | $2.24 | $92,567 | 543,585 | D |
| Derivatives | |||||||
| Dmytruk Mark E. See remarks | 2023-09-01 | Option exercise · Restricted Stock Units | −65,282 | 1,169,913 | D | ||
| Dmytruk Mark E. See remarks | 2023-09-01 | Option exercise · Restricted Stock Units | −18,125 | 761,250 | D | ||
| Dmytruk Mark E. See remarks | 2023-09-01 | Option exercise · Class B Common Stock | −1,636 | 640,137 | D | ||
| Open-market sales · 41,417 sh · avg $2.24 · $92,567 | |||||||
Loading xslF345X05/form4.xml…